RYTM R&D to Revenue
Rhythm Pharmaceuticals Inc · R&D to Revenue
RYTM R&D to Revenue
Latest reported60.95%period ending
RYTM Quarterly R&D/Revenue (0.00% → 60.95%)
Latest values, visible window
High-resolution chart · PNG
RYTM r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 60.9473% | |
| 69.4121% | |
| 73.4162% | |
| 89.7228% | |
| 87.2294% | |
| 113.0534% | |
| 98.4174% | |
| 114.0748% | |
| 103.2292% | |
| 494.7587% | |
| 123.3474% | |
| 149.1735% | |
| 174.5123% | |
| 330.8484% | |
| 267.8953% | |
| 492.9038% | |
| 346.9667% | |
| 2,170.227% | |
| 1,737.6995% | |
| 2,678.8911% | |
| 9,162.0438% | |
| 56,888.5714% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |